High serum vascular endothelial growth factor level is an adverse prognostic factor for high-risk diffuse large B-cell lymphoma patients treated with dose-dense chemoimmunotherapy

✍ Scribed by Sari Riihijärvi; Heidi Nurmi; Harald Holte; Magnus Björkholm; Øystein Fluge; Lars Møller Pedersen; Karin Rydström; Mats Jerkeman; Mikael Eriksson; Sirpa Leppä

• Book ID: 117940369
• Publisher: John Wiley and Sons
• Year: 2012
• Tongue: English
• Weight: 199 KB
• Volume: 89
• Category: Article
• ISSN: 0902-4441
• DOI: 10.1111/ejh.12005